Ameritas Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$589K	Buy	9,718 +943	+11%	+$55K	0.02%	529
2025 Q4	$473K	Buy	8,775 +607	+7%	+$29.2K	0.02%	585
2025 Q3	$368K	Buy	8,168 +11	+0.1%	+$514	0.02%	475
2025 Q2	$378K	Sell	8,157 -5,891	-42%	-$289K	0.02%	573
2025 Q1	$824K	Sell	14,048 -1,759	-11%	-$103K	0.03%	453
2024 Q4	$894K	Buy	15,807 +1,357	+9%	+$75.8K	0.03%	447
2024 Q3	$748K	Sell	14,450 -785	-5%	-$36.8K	0.03%	447
2024 Q2	$633K	Sell	15,235 -2,029	-12%	-$90.8K	0.02%	519
2024 Q1	$842K	Buy	17,264 +9,334	+118%	+$475K	0.03%	420
2023 Q4	$399K	Sell	7,930 -9,392	-54%	-$493K	0.02%	480
2023 Q3	$996K	Buy	17,322 +9,961	+135%	+$610K	0.05%	339
2023 Q2	$461K	Sell	7,361 -8,690	-54%	-$583K	0.06%	313
2023 Q1	$1.12M	Sell	16,051 -5,373	-25%	-$379K	0.06%	299
2022 Q4	$1.54M	Buy	21,424 +1,859	+10%	+$140K	0.07%	262
2022 Q3	$1.39M	Buy	19,565 +338	+2%	+$24.5K	0.08%	233
2022 Q2	$1.48M	Buy	19,227 +660	+4%	+$50.3K	0.09%	227
2022 Q1	$1.36M	Buy	18,567 +421	+2%	+$28.3K	0.05%	277
2021 Q4	$1.13M	Buy	+18,146	New	+$1.06M	0.04%	314